Posted on 2/21/17
Warren Buffett's 5 Best-Performing Stocks of the Past Year
Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B), the conglomerate led by Warren Buffett, has delivered strong returns for investors lately, with shares up 30% over the past year. As . . .
Posted on 2/21/17
Charles River Laboratories Is A Wonderful Business At A Wonderful Price
Drug development goes through several basic stages: Discovery (initial research), pre-clinical (laboratory and animal testing), clinical (Phase I, II, and III human testing), FDA review (approval . . .
Posted on 2/20/17
Mercy Health and Kyruus Forge Strategic Partnership
BOSTON--(BUSINESS WIRE)--Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that Mercy Health (based in Cincinnati, Ohio) has entered into a . . .
Posted on 2/17/17
John D. Nash Elected to Children’s Hospital Association 2017 Board of Trustees
John D. Nash, President and Chief Executive Officer of Franciscan Children’s, has been elected to the Board of
Posted on 2/17/17
How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners
Warfarin may have dominanted the $10 billion market for anticoagulants for the past 50 or so years, but a new class of drugs that works in . . .
Posted on 2/17/17
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
"A billion here, a billion there, and pretty soon you're talking about real money."It's debatable who first uttered that phrase. What isn't debatable, though, is that . . .
Posted on 2/17/17
Ionis and Akcea Close on Strategic Collaboration with Global Pharmaceutical Company
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and Akcea Therapeutics, a wholly-owned subsidiary of Ionis Pharmaceuticals, Inc., announced today they have closed on their exclusive, worldwide option and . . .
Posted on 2/17/17
FORTUNE Recognizes CVS Health on List of "World's Most Admired Companies"
CVS Health (NYSE: CVS), the nation's largest pharmacy innovation company, today was named one of the World's Most Admired Companies by FORTUNE® magazine. CVS Health was . . .
Posted on 2/17/17
Biostage Closes $8.0 Million Public Offering
Biostage, Inc. (Nasdaq: BSTG), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, announced today . . .
Posted on 2/17/17
Philips and The Health Management Academy Collaborate with Top U.S. Health Systems
ANDOVER, Mass.--(BUSINESS WIRE)--Philips and The Health Management Academy announced they would be teaming up for the next three years on an educational initiative to launch The . . .
Posted on 2/16/17
Bpifrance Awards PathMaker Neurosystems a PIA Grant to Support Product Development
PathMaker Neurosystems Inc, a clinical-stage neuromodulation company developing non-invasive systems for the treatment of patients with neuromotor disorders, announced today that Bpifrance has awarded the Company . . .
Posted on 2/15/17
United Natural Foods Expanding in Rhode Island
Rhode Island Governor Gina M. Raimondo and the Rhode Island Commerce Corporation today announced that United Natural Foods Inc. (UNFI) intends to significantly expand its footprint . . .
Posted on 2/15/17
Frisbie Memorial Hospital Wound Center Earns National Award
Frisbie Memorial Hospital's Wound Center has been recognized with a national award for continued excellence in wound healing. The Center for Wound Care and Hyperbaric Medicine . . .
Posted on 2/15/17
X-Chem Expands Collaboration with Janssen in Inflammatory Diseases
WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc. (X-Chem) announced today that it has expanded its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & . . .
Posted on 2/15/17
Transcend Insights and athenahealth Announce Interoperability Partnership
CAMPBELL, Calif. & WATERTOWN, Mass.--(BUSINESS WIRE)--Transcend Insights®, a population health management company and athenahealthInc. (NASDAQ:ATHN), a leading provider of network-enabled services and point-of-care mobile applications for . . .
Posted on 2/15/17
MCG Health and InterSystems Partner
CAMBRIDGE, Mass. & SEATTLE--(BUSINESS WIRE)--InterSystems, a global leader in health information technology, today announced a partnership with MCG Health, a leading provider of informed care solutions. . . .
Posted on 2/15/17
Interleukin Genetics and Pittsburgh Business Group on Health Forge Relationship
Interleukin Genetics, Inc. (OTCQB: ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has entered into a relationship with . . .
Posted on 2/14/17
United Health Foundation Announces Two New Partnerships and Nearly $2.5 Million in Funding
HARTFORD, Conn.--(BUSINESS WIRE)--To address growing teen drug use and provide integrated health care for local Connecticut families, United Health Foundation, Governor Dannel P. Malloy, The Governor’s . . .
Posted on 2/14/17
Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced the start of a Phase 2 trial of an investigational oral therapy . . .
Posted on 2/14/17
Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb
Two hot cancer drugs are being marketed by two very different companies. Cabometyx is Exelixis' (NASDAQ:EXEL) crown jewel. Opdivo is Bristol-Myers Squibb's (NYSE:BMY) rising star.But Bristol-Myers . . .
Posted on 2/13/17
NanoViricides Reports the Company's Director Dr. Boniuk Converted Series B Debenture to Equity Effectively Raising $5M in New Equity for the Company
NanoViricides, Inc. (NYSE MKT: NNVC), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, reports today that a . . .
Posted on 2/13/17
Is Merrimack Pharmaceuticals Worth Stashing in Portfolios?
Biotech investors can make big profits when clinical-stage biotech stocks net wins from the U.S. Food and Drug Administration, but in the case of Merrimack Pharmaceuticals(NASDAQ:MACK), . . .
Posted on 2/12/17
Biostage Announces $8.0 Million Public Offering
Biostage, Inc. (Nasdaq: BSTG), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, announced today . . .
Posted on 2/10/17
Bristol-Myers Squibb: Much Ado About (Almost) Nothing
"Mors tua, vita mea" (literally "your death is my life) probably was the motto that gladiators, in the ancient Rome, recited before entering in the Coliseum . . .
Posted on 2/9/17
Emerging Trends in Wellness Conference Features Speakers from Constant Contact, Tufts Health Plan, Harvard Medical School and BJ’s Wholesale Club
Wellness Workdays, a leading provider of worksite wellness programs, hosts its 4th Annual Conference “Emerging Trends in Wellness” April 5-6 at Lombardo’s Conference Center outside of . . .
Boston
